Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Arcadia Biosciences (RKDA) Invested Capital (2016 - 2025)

Historic Invested Capital for Arcadia Biosciences (RKDA) over the last 12 years, with Q3 2025 value amounting to $5.4 million.

  • Arcadia Biosciences' Invested Capital fell 4708.86% to $5.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.4 million, marking a year-over-year decrease of 4708.86%. This contributed to the annual value of $6.2 million for FY2024, which is 5153.8% down from last year.
  • Per Arcadia Biosciences' latest filing, its Invested Capital stood at $5.4 million for Q3 2025, which was down 4708.86% from $4.5 million recorded in Q2 2025.
  • Arcadia Biosciences' Invested Capital's 5-year high stood at $46.8 million during Q1 2021, with a 5-year trough of $4.5 million in Q2 2025.
  • Moreover, its 5-year median value for Invested Capital was $16.8 million (2023), whereas its average is $20.3 million.
  • In the last 5 years, Arcadia Biosciences' Invested Capital soared by 28274.37% in 2021 and then crashed by 6126.97% in 2025.
  • Over the past 5 years, Arcadia Biosciences' Invested Capital (Quarter) stood at $31.3 million in 2021, then plummeted by 32.56% to $21.1 million in 2022, then tumbled by 39.09% to $12.8 million in 2023, then tumbled by 51.54% to $6.2 million in 2024, then decreased by 12.53% to $5.4 million in 2025.
  • Its Invested Capital was $5.4 million in Q3 2025, compared to $4.5 million in Q2 2025 and $8.9 million in Q1 2025.